[go: up one dir, main page]

AU2001241942A1 - Melanoma differentiation associated gene - 7 promoter and uses thereof - Google Patents

Melanoma differentiation associated gene - 7 promoter and uses thereof

Info

Publication number
AU2001241942A1
AU2001241942A1 AU2001241942A AU4194201A AU2001241942A1 AU 2001241942 A1 AU2001241942 A1 AU 2001241942A1 AU 2001241942 A AU2001241942 A AU 2001241942A AU 4194201 A AU4194201 A AU 4194201A AU 2001241942 A1 AU2001241942 A1 AU 2001241942A1
Authority
AU
Australia
Prior art keywords
promoter
associated gene
melanoma differentiation
differentiation associated
melanoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001241942A
Inventor
Paul B. Fisher
Malavi T. Madireddi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Columbia University in the City of New York
Original Assignee
Columbia University in the City of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia University in the City of New York filed Critical Columbia University in the City of New York
Publication of AU2001241942A1 publication Critical patent/AU2001241942A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001241942A 2000-02-29 2001-02-28 Melanoma differentiation associated gene - 7 promoter and uses thereof Abandoned AU2001241942A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/515,369 US6841362B1 (en) 2000-02-29 2000-02-29 Melanoma differentiation associated gene-7 promoter and uses thereof
US09515369 2000-02-29
PCT/US2001/006782 WO2001064921A1 (en) 2000-02-29 2001-02-28 Melanoma differentiation associated gene - 7 promoter and uses thereof

Publications (1)

Publication Number Publication Date
AU2001241942A1 true AU2001241942A1 (en) 2001-09-12

Family

ID=24051062

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001241942A Abandoned AU2001241942A1 (en) 2000-02-29 2001-02-28 Melanoma differentiation associated gene - 7 promoter and uses thereof

Country Status (3)

Country Link
US (1) US6841362B1 (en)
AU (1) AU2001241942A1 (en)
WO (1) WO2001064921A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100917939B1 (en) * 2001-03-09 2009-09-21 진 스트림 피티와이 리미티드 Novel expression vectors
EP2182059A1 (en) * 2002-09-16 2010-05-05 Promega Corporation Rapidly degraded reporter fusion proteins
WO2004064868A1 (en) * 2003-01-22 2004-08-05 Magnus Essand Tarp promoter and uses thereof
RU2499599C2 (en) * 2007-09-28 2013-11-27 Интрексон Корпорейшн Therapeutic gene switching constructs and bioreactors for expressing biotherapeutic molecules and using them
CN117448332B (en) * 2023-08-07 2025-06-24 大连理工大学 Sequence optimization method for enhancing mRNA protein expression by using RNA binding protein

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990011092A1 (en) 1989-03-21 1990-10-04 Vical, Inc. Expression of exogenous polynucleotide sequences in a vertebrate
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
CA2135312C (en) 1992-05-13 2006-09-26 Charles Myers Use of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme a reductase as a modality in cancer therapy
US5496731A (en) 1993-03-25 1996-03-05 Xu; Hong-Ji Broad-spectrum tumor suppressor genes, gene products and methods for tumor suppressor gene therapy
US6051376A (en) 1994-09-30 2000-04-18 The Trustees Of Columbia University In The City Of New York Uses of mda-6
WO1995011986A1 (en) 1993-10-27 1995-05-04 The Trustees Of Columbia University In The City Of New York METHOD FOR GENERATING A SUBTRACTED cDNA LIBRARY AND USES OF THE GENERATED LIBRARY
US5643761A (en) 1993-10-27 1997-07-01 The Trustees Of Columbia University In The City Of New York Method for generating a subtracted cDNA library and uses of the generated library
US6025127A (en) 1994-01-14 2000-02-15 The Johns Hopkins University School Of Medicine Nucleic acid mutation detection in histologic tissue
US5710137A (en) 1996-08-16 1998-01-20 The Trustees Of Columbia University In The City Of New York Use of a melanoma differentiation associated gene (mda 7) for reversing a cancerous phenotype

Also Published As

Publication number Publication date
US6841362B1 (en) 2005-01-11
WO2001064921A1 (en) 2001-09-07

Similar Documents

Publication Publication Date Title
AU2002315389A1 (en) Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
AU7563800A (en) Marsh-mallow and the marsh-mallow production technique
AU1890599A (en) Novel microorganism and use thereof
AU4431000A (en) Novel use
AU2001240637A1 (en) Novel imidazotriazinones and the use thereof
AU2002219135A1 (en) Substituted 2-anilino-benzimidazoles and the use thereof as NHE-inhibitors
AU2002315388A1 (en) Novel phenylamino-pyrimidines and uses thereof
AU2001231532A1 (en) Improved interleukin 10
AU2678800A (en) Modified calycins
AU1403501A (en) Novel composition and use
AU2002211717A1 (en) Stresscopins and their uses
AU7073800A (en) Novel plexins and uses thereof
AU2001284418A1 (en) Novel polypeptide
AU3072500A (en) Rhamnosyl-transferase gene and uses thereof
AU2841801A (en) Triazolotriazinones and the use thereof
AU2001247274A1 (en) Melanoma differentiation associated gene - 5 and promoter and uses thereof
AU2001265096A1 (en) Short-root gene, promoter, and uses thereof
AU5706000A (en) Useful polypeptide
AU2002224876A1 (en) Isolated luciferases and the use thereof
AU2002228921A1 (en) Arcelin-5 promoter and uses thereof
AU2001241942A1 (en) Melanoma differentiation associated gene - 7 promoter and uses thereof
AU2001262963A1 (en) Laminin 15 and uses thereof
AU1894601A (en) Novel gene and use thereof
AU2001237592A1 (en) Enzymes and uses relating thereto
AU9263598A (en) New tissue-specific calpaines, their production and their use